Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121

Broadly neutralising antibodies (bNAbs) may play an important role in future strategies for HIV control. The development of anti-drug antibody (ADA) responses can reduce the efficacy of passively transferred bNAbs but the impact of ADA is imperfectly understood. We previously showed that therapeutic...

Full description

Bibliographic Details
Main Authors: Wen Shi Lee, Arnold Reynaldi, Thakshila Amarasena, Miles P. Davenport, Matthew S. Parsons, Stephen J. Kent
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.749891/full
_version_ 1819000504718458880
author Wen Shi Lee
Arnold Reynaldi
Thakshila Amarasena
Miles P. Davenport
Matthew S. Parsons
Matthew S. Parsons
Matthew S. Parsons
Stephen J. Kent
Stephen J. Kent
author_facet Wen Shi Lee
Arnold Reynaldi
Thakshila Amarasena
Miles P. Davenport
Matthew S. Parsons
Matthew S. Parsons
Matthew S. Parsons
Stephen J. Kent
Stephen J. Kent
author_sort Wen Shi Lee
collection DOAJ
description Broadly neutralising antibodies (bNAbs) may play an important role in future strategies for HIV control. The development of anti-drug antibody (ADA) responses can reduce the efficacy of passively transferred bNAbs but the impact of ADA is imperfectly understood. We previously showed that therapeutic administration of the anti-HIV bNAb PGT121 (either WT or LALA version) controlled viraemia in pigtailed macaques with ongoing SHIV infection. We now report on 23 macaques that had multiple treatments with PGT121. We found that an increasing number of intravenous doses of PGT121 or human IgG1 isotype control antibodies (2-4 doses) results in anti-PGT121 ADA induction and low plasma concentrations of PGT121. ADA was associated with poor or absent suppression of SHIV viremia. Notably, ADA within macaque plasma recognised another human bNAb 10E8 but did not bind to the variable domains of PGT121, suggesting that ADA were primarily directed against the constant regions of the human antibodies. These findings have implications for the development of preclinical studies examining multiple infusions of human bNAbs.
first_indexed 2024-12-20T22:34:22Z
format Article
id doaj.art-099d8252a5c742e2aa9272fa91e71d68
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-20T22:34:22Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-099d8252a5c742e2aa9272fa91e71d682022-12-21T19:24:38ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-11-011210.3389/fimmu.2021.749891749891Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121Wen Shi Lee0Arnold Reynaldi1Thakshila Amarasena2Miles P. Davenport3Matthew S. Parsons4Matthew S. Parsons5Matthew S. Parsons6Stephen J. Kent7Stephen J. Kent8Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, AustraliaKirby Institute, University of New South Wales, Kensington, NSW, AustraliaDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, AustraliaKirby Institute, University of New South Wales, Kensington, NSW, AustraliaDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, AustraliaDepartment of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, United StatesYerkes National Primate Research Center, Emory University, Atlanta, GA, United StatesDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, AustraliaMelbourne Sexual Health Centre and Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, AustraliaBroadly neutralising antibodies (bNAbs) may play an important role in future strategies for HIV control. The development of anti-drug antibody (ADA) responses can reduce the efficacy of passively transferred bNAbs but the impact of ADA is imperfectly understood. We previously showed that therapeutic administration of the anti-HIV bNAb PGT121 (either WT or LALA version) controlled viraemia in pigtailed macaques with ongoing SHIV infection. We now report on 23 macaques that had multiple treatments with PGT121. We found that an increasing number of intravenous doses of PGT121 or human IgG1 isotype control antibodies (2-4 doses) results in anti-PGT121 ADA induction and low plasma concentrations of PGT121. ADA was associated with poor or absent suppression of SHIV viremia. Notably, ADA within macaque plasma recognised another human bNAb 10E8 but did not bind to the variable domains of PGT121, suggesting that ADA were primarily directed against the constant regions of the human antibodies. These findings have implications for the development of preclinical studies examining multiple infusions of human bNAbs.https://www.frontiersin.org/articles/10.3389/fimmu.2021.749891/fullHIVbroadly neutralizing antibodies (bNAb)PGT121anti-drug antibodies (ADA)pigtailed macaque
spellingShingle Wen Shi Lee
Arnold Reynaldi
Thakshila Amarasena
Miles P. Davenport
Matthew S. Parsons
Matthew S. Parsons
Matthew S. Parsons
Stephen J. Kent
Stephen J. Kent
Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
Frontiers in Immunology
HIV
broadly neutralizing antibodies (bNAb)
PGT121
anti-drug antibodies (ADA)
pigtailed macaque
title Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
title_full Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
title_fullStr Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
title_full_unstemmed Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
title_short Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
title_sort anti drug antibodies in pigtailed macaques receiving hiv broadly neutralising antibody pgt121
topic HIV
broadly neutralizing antibodies (bNAb)
PGT121
anti-drug antibodies (ADA)
pigtailed macaque
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.749891/full
work_keys_str_mv AT wenshilee antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT arnoldreynaldi antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT thakshilaamarasena antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT milespdavenport antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT matthewsparsons antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT matthewsparsons antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT matthewsparsons antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT stephenjkent antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT stephenjkent antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121